Pomalidomide-PEG1-COOH
Biomedicine 2025-03-04
CAS NO.: 2139348-60-8
Product purity: ≥95%
Molecular formula: C18H19N3O7
Molecular weight: 389.36
Product Usage: Applied to medical research, drug release, nanotechnology and new material research, cell culture. As well as in ligand research, peptide synthesis support, grafted polymer compounds, new materials and polyethylene glycol modified functional coatings and other active compounds.
Additional Information of Pomalidomide-PEG1-COOH
| Item | Information |
|---|---|
| Synonyms | Pomalidomide-PEG1-C₂-COOH, Pomalidomide 4′-PEG1-acid, 3-(2-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)ethoxy)propanoic acid |
| Solubility | DMSO: 100 mg/mL (256.8 mM), sonication recommended |
| Application | Used as an E3 ligase ligand-linker conjugate in PROTAC technology for targeted protein degradation |
| Purity | ≥95% |
Disclaimer: The above content is for reference and communication only among industry insiders, and does not guarantee its accuracy or completeness. According to relevant laws and regulations and the regulations of this website, units or individuals who purchase related items should obtain valid qualifications and qualification conditions.
